Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)

Aurisco Pharmaceutical Revenue

Aurisco Pharmaceutical had revenue of 439.11M CNY in the quarter ending June 30, 2026, with 4.56% growth. This brings the company's total for the last twelve months to 1.70B, up 8.73% year-over-year. In the year 2025, Aurisco Pharmaceutical had annual revenue of 1.70B with 15.03% growth. That makes Aurisco Pharmaceutical the 15,651st largest company in the world by revenue and 2,807th in China.

• Revenue (ttm): 1.70B
• Revenue Growth: +8.73%
• P/S Ratio: 4.35
• Revenue / Employee: 841.01K
• Employees: 2,026
• Market Cap: 7.48B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Sales of active pharmaceutical ingredients and Intermediates 1.47B 86.5%
• Sale of Drug Product 184.40M 10.9%
• Trading of active pharmaceutical ingredients and intermediates 36.00M 2.1%
• Others 8.73M 0.5%

By Geography

Chart

• Overseas 1.35B 79.6%
• China 345.96M 20.4%

Fiscal year ended Dec 31, 2025 See the full Aurisco Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.70B	221.74M	15.03%
Dec 31, 2024	1.48B	213.21M	16.89%
Dec 31, 2023	1.26B	254.45M	25.24%
Dec 31, 2022	1.01B	204.71M	25.48%
Dec 31, 2021	803.36M	81.92M	11.36%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error